nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dexamethasone—ankylosing spondylitis	0.119	0.212	CbGbCtD
Fingolimod—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0953	0.17	CbGbCtD
Fingolimod—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0722	0.129	CbGbCtD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—EDIL3—ankylosing spondylitis	0.0632	0.252	CbGpPWpGaD
Fingolimod—CYP3A4—Betamethasone—ankylosing spondylitis	0.062	0.111	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—ankylosing spondylitis	0.0611	0.109	CbGbCtD
Fingolimod—CYP3A4—Prednisone—ankylosing spondylitis	0.0577	0.103	CbGbCtD
Fingolimod—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0567	0.101	CbGbCtD
Fingolimod—S1PR4—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0429	0.171	CbGpPWpGaD
Fingolimod—S1PR3—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0413	0.165	CbGpPWpGaD
Fingolimod—S1PR1—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0375	0.149	CbGpPWpGaD
Fingolimod—CYP3A4—Dexamethasone—ankylosing spondylitis	0.036	0.0644	CbGbCtD
Fingolimod—Lymphoproliferative disorder—Methotrexate—ankylosing spondylitis	0.0104	0.0695	CcSEcCtD
Fingolimod—X-linked lymphoproliferative syndrome—Methotrexate—ankylosing spondylitis	0.0104	0.0695	CcSEcCtD
Fingolimod—Depressed mood—Methylprednisolone—ankylosing spondylitis	0.00474	0.0318	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00456	0.0182	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00439	0.0175	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00439	0.0175	CbGpPWpGaD
Fingolimod—SPHK1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00418	0.105	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00418	0.105	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00411	0.104	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00411	0.104	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00402	0.101	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00402	0.101	CbGdCrCtD
Fingolimod—Lymphoma—Methotrexate—ankylosing spondylitis	0.00401	0.0269	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00399	0.0159	CbGpPWpGaD
Fingolimod—SPHK1—Betamethasone—Prednisone—ankylosing spondylitis	0.00381	0.0961	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—ankylosing spondylitis	0.00381	0.0961	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00372	0.0938	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00372	0.0938	CbGdCrCtD
Fingolimod—S1PR4—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00347	0.0138	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00334	0.0133	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00334	0.0133	CbGpPWpGaD
Fingolimod—Lymphopenia—Prednisone—ankylosing spondylitis	0.00328	0.022	CcSEcCtD
Fingolimod—Visual acuity reduced—Dexamethasone—ankylosing spondylitis	0.00324	0.0217	CcSEcCtD
Fingolimod—Visual acuity reduced—Betamethasone—ankylosing spondylitis	0.00324	0.0217	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00304	0.0121	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.00276	0.011	CbGpPWpGaD
Fingolimod—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00256	0.0172	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00196	0.00782	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—B3GNT2—ankylosing spondylitis	0.00192	0.00763	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00189	0.00753	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00189	0.00753	CbGpPWpGaD
Fingolimod—Herpes zoster—Methotrexate—ankylosing spondylitis	0.00186	0.0125	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00178	0.0071	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00172	0.00684	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00172	0.00684	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00172	0.00684	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—B3GNT2—ankylosing spondylitis	0.00165	0.00659	CbGpPWpGaD
Fingolimod—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00159	0.0107	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00156	0.00621	CbGpPWpGaD
Fingolimod—Eye pain—Dexamethasone—ankylosing spondylitis	0.00155	0.0104	CcSEcCtD
Fingolimod—Eye pain—Betamethasone—ankylosing spondylitis	0.00155	0.0104	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00148	0.00995	CcSEcCtD
Fingolimod—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00147	0.00984	CcSEcCtD
Fingolimod—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00146	0.00981	CcSEcCtD
Fingolimod—SPHK1—Metabolism—B3GNT2—ankylosing spondylitis	0.00142	0.00566	CbGpPWpGaD
Fingolimod—Migraine—Dexamethasone—ankylosing spondylitis	0.00138	0.00924	CcSEcCtD
Fingolimod—Migraine—Betamethasone—ankylosing spondylitis	0.00138	0.00924	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00136	0.0091	CcSEcCtD
Fingolimod—Influenza—Triamcinolone—ankylosing spondylitis	0.00133	0.00894	CcSEcCtD
Fingolimod—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00133	0.00892	CcSEcCtD
Fingolimod—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00133	0.00892	CcSEcCtD
Fingolimod—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00128	0.0086	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00127	0.00506	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00122	0.00487	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00122	0.00487	CbGpPWpGaD
Fingolimod—Infestation—Methylprednisolone—ankylosing spondylitis	0.00119	0.00795	CcSEcCtD
Fingolimod—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00119	0.00795	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—ankylosing spondylitis	0.00118	0.00792	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00116	0.00777	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00111	0.00442	CbGpPWpGaD
Fingolimod—Weight decreased—Betamethasone—ankylosing spondylitis	0.00109	0.00734	CcSEcCtD
Fingolimod—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00109	0.00734	CcSEcCtD
Fingolimod—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00109	0.00728	CcSEcCtD
Fingolimod—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00108	0.00727	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00107	0.00721	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00105	0.00419	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00105	0.00702	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00104	0.00697	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00101	0.00404	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00101	0.00404	CbGpPWpGaD
Fingolimod—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000995	0.00667	CcSEcCtD
Fingolimod—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000988	0.00663	CcSEcCtD
Fingolimod—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000985	0.00661	CcSEcCtD
Fingolimod—Bradycardia—Betamethasone—ankylosing spondylitis	0.000985	0.00661	CcSEcCtD
Fingolimod—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000966	0.00648	CcSEcCtD
Fingolimod—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000959	0.00643	CcSEcCtD
Fingolimod—Weight decreased—Prednisone—ankylosing spondylitis	0.000953	0.00639	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—ankylosing spondylitis	0.000952	0.00638	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00094	0.00631	CcSEcCtD
Fingolimod—Depression—Prednisone—ankylosing spondylitis	0.000936	0.00628	CcSEcCtD
Fingolimod—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000932	0.00626	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000921	0.00367	CbGpPWpGaD
Fingolimod—Eye disorder—Betamethasone—ankylosing spondylitis	0.000904	0.00607	CcSEcCtD
Fingolimod—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000904	0.00607	CcSEcCtD
Fingolimod—Back pain—Triamcinolone—ankylosing spondylitis	0.000898	0.00603	CcSEcCtD
Fingolimod—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000878	0.00589	CcSEcCtD
Fingolimod—Angiopathy—Betamethasone—ankylosing spondylitis	0.000878	0.00589	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—ankylosing spondylitis	0.000872	0.00585	CcSEcCtD
Fingolimod—Bradycardia—Prednisone—ankylosing spondylitis	0.000858	0.00576	CcSEcCtD
Fingolimod—Alopecia—Betamethasone—ankylosing spondylitis	0.000855	0.00574	CcSEcCtD
Fingolimod—Alopecia—Dexamethasone—ankylosing spondylitis	0.000855	0.00574	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000828	0.00556	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000815	0.00325	CbGpPWpGaD
Fingolimod—Cough—Triamcinolone—ankylosing spondylitis	0.00081	0.00544	CcSEcCtD
Fingolimod—Hypertension—Triamcinolone—ankylosing spondylitis	0.000802	0.00538	CcSEcCtD
Fingolimod—Hypertension—Methylprednisolone—ankylosing spondylitis	0.0008	0.00537	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—ankylosing spondylitis	0.000789	0.00529	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—ankylosing spondylitis	0.000788	0.00528	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000785	0.00526	CcSEcCtD
Fingolimod—Infestation—Methotrexate—ankylosing spondylitis	0.000785	0.00526	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000783	0.00525	CcSEcCtD
Fingolimod—Depression—Methotrexate—ankylosing spondylitis	0.000782	0.00525	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—ankylosing spondylitis	0.000765	0.00513	CcSEcCtD
Fingolimod—Infection—Triamcinolone—ankylosing spondylitis	0.000753	0.00505	CcSEcCtD
Fingolimod—Infection—Methylprednisolone—ankylosing spondylitis	0.000751	0.00504	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—MMP3—ankylosing spondylitis	0.00075	0.00299	CbGpPWpGaD
Fingolimod—Alopecia—Prednisone—ankylosing spondylitis	0.000745	0.005	CcSEcCtD
Fingolimod—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000742	0.00497	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00074	0.00496	CcSEcCtD
Fingolimod—Mental disorder—Prednisone—ankylosing spondylitis	0.000738	0.00495	CcSEcCtD
Fingolimod—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000734	0.00493	CcSEcCtD
Fingolimod—Hypertension—Betamethasone—ankylosing spondylitis	0.000727	0.00488	CcSEcCtD
Fingolimod—Hypertension—Dexamethasone—ankylosing spondylitis	0.000727	0.00488	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000722	0.00288	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP3—ankylosing spondylitis	0.000722	0.00288	CbGpPWpGaD
Fingolimod—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000707	0.00474	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—ankylosing spondylitis	0.000691	0.00464	CcSEcCtD
Fingolimod—Infection—Dexamethasone—ankylosing spondylitis	0.000683	0.00458	CcSEcCtD
Fingolimod—Infection—Betamethasone—ankylosing spondylitis	0.000683	0.00458	CcSEcCtD
Fingolimod—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00068	0.00456	CcSEcCtD
Fingolimod—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000679	0.00455	CcSEcCtD
Fingolimod—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000676	0.00453	CcSEcCtD
Fingolimod—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000674	0.00452	CcSEcCtD
Fingolimod—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000674	0.00452	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—ankylosing spondylitis	0.000658	0.00442	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000655	0.00261	CbGpPWpGaD
Fingolimod—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000654	0.00439	CcSEcCtD
Fingolimod—Fatigue—Triamcinolone—ankylosing spondylitis	0.000653	0.00438	CcSEcCtD
Fingolimod—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000652	0.00437	CcSEcCtD
Fingolimod—Hypotension—Dexamethasone—ankylosing spondylitis	0.000643	0.00431	CcSEcCtD
Fingolimod—Hypotension—Betamethasone—ankylosing spondylitis	0.000643	0.00431	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—ankylosing spondylitis	0.000639	0.00429	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000635	0.00426	CcSEcCtD
Fingolimod—Hypertension—Prednisone—ankylosing spondylitis	0.000633	0.00425	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—ankylosing spondylitis	0.000622	0.00418	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00062	0.00416	CcSEcCtD
Fingolimod—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000617	0.00414	CcSEcCtD
Fingolimod—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000617	0.00414	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—ankylosing spondylitis	0.000617	0.00414	CcSEcCtD
Fingolimod—Infection—Prednisone—ankylosing spondylitis	0.000595	0.00399	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000594	0.00398	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000594	0.00398	CcSEcCtD
Fingolimod—Back pain—Methotrexate—ankylosing spondylitis	0.000593	0.00398	CcSEcCtD
Fingolimod—Fatigue—Betamethasone—ankylosing spondylitis	0.000593	0.00398	CcSEcCtD
Fingolimod—Fatigue—Dexamethasone—ankylosing spondylitis	0.000593	0.00398	CcSEcCtD
Fingolimod—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000587	0.00394	CcSEcCtD
Fingolimod—Skin disorder—Prednisone—ankylosing spondylitis	0.000582	0.0039	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—MMP3—ankylosing spondylitis	0.00058	0.00231	CbGpPWpGaD
Fingolimod—Vision blurred—Methotrexate—ankylosing spondylitis	0.000578	0.00388	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—ankylosing spondylitis	0.000549	0.00368	CcSEcCtD
Fingolimod—Dizziness—Prednisolone—ankylosing spondylitis	0.000545	0.00366	CcSEcCtD
Fingolimod—Asthenia—Triamcinolone—ankylosing spondylitis	0.000544	0.00365	CcSEcCtD
Fingolimod—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000543	0.00364	CcSEcCtD
Fingolimod—Paraesthesia—Prednisone—ankylosing spondylitis	0.000538	0.00361	CcSEcCtD
Fingolimod—Pruritus—Triamcinolone—ankylosing spondylitis	0.000536	0.0036	CcSEcCtD
Fingolimod—Cough—Methotrexate—ankylosing spondylitis	0.000535	0.00359	CcSEcCtD
Fingolimod—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000535	0.00359	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000518	0.00348	CcSEcCtD
Fingolimod—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000517	0.00347	CcSEcCtD
Fingolimod—Fatigue—Prednisone—ankylosing spondylitis	0.000516	0.00346	CcSEcCtD
Fingolimod—Headache—Prednisolone—ankylosing spondylitis	0.000516	0.00346	CcSEcCtD
Fingolimod—Dizziness—Triamcinolone—ankylosing spondylitis	0.000501	0.00336	CcSEcCtD
Fingolimod—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0005	0.00335	CcSEcCtD
Fingolimod—Infection—Methotrexate—ankylosing spondylitis	0.000497	0.00334	CcSEcCtD
Fingolimod—Asthenia—Dexamethasone—ankylosing spondylitis	0.000493	0.00331	CcSEcCtD
Fingolimod—Asthenia—Betamethasone—ankylosing spondylitis	0.000493	0.00331	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000491	0.00329	CcSEcCtD
Fingolimod—Pruritus—Betamethasone—ankylosing spondylitis	0.000486	0.00326	CcSEcCtD
Fingolimod—Pruritus—Dexamethasone—ankylosing spondylitis	0.000486	0.00326	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—ankylosing spondylitis	0.000486	0.00326	CcSEcCtD
Fingolimod—Headache—Triamcinolone—ankylosing spondylitis	0.000475	0.00318	CcSEcCtD
Fingolimod—Headache—Methylprednisolone—ankylosing spondylitis	0.000474	0.00318	CcSEcCtD
Fingolimod—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00047	0.00316	CcSEcCtD
Fingolimod—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00047	0.00316	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—ankylosing spondylitis	0.000468	0.00314	CcSEcCtD
Fingolimod—Dizziness—Betamethasone—ankylosing spondylitis	0.000455	0.00305	CcSEcCtD
Fingolimod—Dizziness—Dexamethasone—ankylosing spondylitis	0.000455	0.00305	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000449	0.00301	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000446	0.00299	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000432	0.0029	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—ankylosing spondylitis	0.000431	0.00289	CcSEcCtD
Fingolimod—Headache—Dexamethasone—ankylosing spondylitis	0.000431	0.00289	CcSEcCtD
Fingolimod—Headache—Betamethasone—ankylosing spondylitis	0.000431	0.00289	CcSEcCtD
Fingolimod—Asthenia—Prednisone—ankylosing spondylitis	0.00043	0.00288	CcSEcCtD
Fingolimod—Pruritus—Prednisone—ankylosing spondylitis	0.000424	0.00284	CcSEcCtD
Fingolimod—Diarrhoea—Prednisone—ankylosing spondylitis	0.00041	0.00275	CcSEcCtD
Fingolimod—Dizziness—Prednisone—ankylosing spondylitis	0.000396	0.00266	CcSEcCtD
Fingolimod—Headache—Prednisone—ankylosing spondylitis	0.000375	0.00252	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—ankylosing spondylitis	0.000359	0.00241	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—ankylosing spondylitis	0.000354	0.00238	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000342	0.0023	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—ankylosing spondylitis	0.000331	0.00222	CcSEcCtD
Fingolimod—Headache—Methotrexate—ankylosing spondylitis	0.000314	0.0021	CcSEcCtD
Fingolimod—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	0.000233	0.000929	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	0.000165	0.000659	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	0.000108	0.000431	CbGpPWpGaD
